| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |